Jade Noble James Ansell

All filings by Jade Noble James Ansell on record concern Musirum Health Science Inc. Over a trading history stretching from 21 April 2022 to 27 September 2023, the count stands at 3 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 24 May 2024, reports a transaction in Musirum Health Science Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.